Cited by 102Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease

Quinn, J·2003·Journal of Neuroimmunology

Abstract

The hypothesis that inflammation and beta amyloid deposition are causally linked in Alzheimer's disease (AD) was tested in a transgenic mouse model. Untreated beta amyloid plaque-bearing Tg2576 mice did not differ from wild type animals in brain levels of most inflammatory mediators. Indomethacin treatment suppressed brain levels of prostaglandins by 90%, but reduced hippocampal beta amyloid by only 20%, with no effect on cortical beta amyloid. The discordant effects on beta amyloid and cyclooxygenase (COX) suggest that these effects of nonsteroidal anti-inflammatory drugs (NSAIDs) are not causally linked. Further evidence against a causal relationship is seen in an unexpected trend to lower levels of beta amyloid after an inflammatory stimulus [lipopolysaccharide (LPS)].

Integrity signals

Registry

Crossref · 10.1016/s0165-5728(03)00037-7

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 44 · Cited by 102

Authors
Quinn, J.
Affiliations
Oregon Health & Science University (US)
Corresponding author
Quinn, J
Venue
Journal of Neuroimmunology
Publisher
Elsevier BV
Published
2003-04
Volume
137
Issue
1-2
Pages
32-41
ISSN
0165-5728 (ISSN-L)
OpenAlex
W2159781448
Cited by
102
References
44
Citations by year
2026: 2 · 2025: 2 · 2024: 2 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 3 · 2015: 4 · 2014: 2 · 2013: 4 · 2012: 6
FWCI
4.22
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neuroimmunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Veterans Affairs
  • National Institute on Aging (AG 00774, AG 08017, AG 16835, AG07424, P30AG008017, R01AG016835)
  • National Center for Complementary and Integrative Health (AT00066-01)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, cerebral amyloidosis, amyloid-beta, neuroinflammation, Tg2576 mice, indomethacin, nonsteroidal anti-inflammatory drugs, cyclooxygenase, prostaglandins, lipopolysaccharide, hippocampus, cortical amyloid, amyloid plaques
MeSH terms
Alzheimer Disease, Amyloidosis, Animals, Anti-Inflammatory Agents, Non-Steroidal, Cerebral Cortex, Disease Models, Animal, Female, Hippocampus, Inflammation, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Transgenic, Cytokines, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review